The Chemical Biological Defense Program (CBDP) fields capabilities to the Joint Force in a core mission area of the DoD to counter Weapons of Mass Destruction (WMDs) and plays a key role in executing the DoD Strategy for countering WMDs. The program principally supports the Priority Objective to deny the effects of current and emerging WMD threats through layered, integrated defenses. It provides direction and enabling capabilities to maintain and expand technical expertise; cooperate with and support partners; understand the threat environment and vulnerabilities to; control, defeat, disable, and/or, dispose of WMD threats; safeguard the force, and manage consequences. The CBDP provides this support as described in the CBDP Strategic Plan.

The CBDP fields capabilities which support the Joint Forces' ability to operate in a Chemical Biological Radiological and Nuclear (CBRN) environment. The CBDP Enterprise is composed of: components, services, and enabling partners. Those organizations with core responsibilities for the CBDP are the components and includes those organizations depicted below.

PRINCIPAL RESPONSIBILITIES OF THE ODASD(CBD)

The management, governance, and resourcing for the CBDP is the responsibility of the USD(A&S) and is performed daily by the DASD(CBD). The DASD(CBD) directs the resources activities (in accordance with DoD and Services priorities) from concept and requirements development, through early science and technology to advanced development, testing and evaluation, procurement, and infrastructure management. The DASD(CBD) will perform the following duties in the conduct of its responsibility:

• Publish program guidance that provides resourcing guidance and translates national, departmental, and service priorities into specific program objectives.
• Ensure that program efforts remain aligned with those priorities and support Countering Weapons of Mass Destruction (CWMD) office guidance and missions.
• Implement and maintain Enterprise Performance Management processes. Measure and assess the CBDP Enterprise's collective performance against strategic goals and objectives identified in the CBDP Strategic Plan, and assessing each component's performance against established criteria and metrics. Identify areas of concern and implement corrective actions through changes in program guidance, directed actions, or by advising and providing recommendations to the ASD(NCB).
• Implement and maintain Enterprise Risk Management processes. Follow guidance of OMB Circular A-11, Section 270 and OMB Circular A-123 in the setup of governance to implement Enterprise Risk Management. Establish risk thresholds and identify top risks to the achievement of the goals and objectives laid out in the CBDP Strategic Plan. Identify areas of concern and implement effective corrective actions through changes in program guidance, directed actions, or by advising and providing recommendations to the ASD(NCB). Establish charters for Enterprise Risk Management working groups as necessary.
• Develop CBDP Research, Development, and Acquisition policy and guidance.
• Monitor execution of funds provided to the CBDP Enterprise.
• Coordinate with the DoD EA for the CBDP for the independent analysis and program integration support.
• Coordinate and integrate Research Development and Acquisition (RDA) activities for joint radiological defense programs; coordinate with the Assistant Secretary of Defense for Health Affairs ASD(HA) for joint radiological medical defense RDA activities.
• Issue annual guidance for financial execution and reporting and oversee day-to-day management of CBDP Defense-Wide accounts.
• Charter governance fora as needed to assist in the conduct of oversight and decision making for the CBDP Enterprise.
• Lead the Enterprise in Strategic Planning and publish the CBDP Strategic Plan quadrennially.

Provides management of the development of Chemical, Biological, and Radiological (CBR) protection that is primarily internal to the body. This includes medical countermeasures, vaccines, therapeutics, and pre-treatments for the Joint Force. The medical programs also focus on the potential emerging threats and technologies that could impact the Warfighter.

Provides management of efforts that provide physical CBR protection external to the body. This includes efforts such as protective masks, suits, boots, detectors, and decontamination for the Joint Force. In addition to improve the Joint Forces' ability to operate in the CBR environment, the physical program focuses on potential emerging threats and technologies that could impact the Warfighter.

Submits the annual Budget Estimate Submission (BES) to the Office of the Under Secretary of Defense (Comptroller) (OUSD(C)) and Office of Management and Budget (OMB).

Submits the President's Budget (PB) to Congress integrating all changes from OUSD(C), the Cost Assessment and Program Evaluation (CAPE), and OMB through the Program and Budget Review (PBR) and issue cycle papers.

Provides management and direction for the CPBP Budget and financials. Interfaces with OUSD(C), CAPE, and OMB who review the Project Objective Memorandum (POM) and BES during the PBR and issue paper cycle to adjudicate issues presented through the PBR and issue paper cycle.

Provides management, staffing, and approval of CBDP budget submission documentation.

OTHER OFFICE RESPONSIBILITIES

Manages the governance processes in the International Programs area work to ensure a coordinated and unified DoD strategy, project portfolio, and position on important international CBD matters. Consistency across DoD's international cooperative program activities is achieved through two structures:

• The International Programs Coordination Group (IPCG), which is a forum and coordinating body for the review of departmental CBD international program activities.
• Transition papers which address specific topics of high priority related to the development and maintenance of CBR defense strategic alliances and partnerships. These partnerships include interagency and international cooperation, as well as engagements with academia, industry, and non-government organizations.

Partnership between the CBDP and other U.S. Government departments and agencies is not only a DoD best-practice; it is also mandated by law.

Manages the governance processes of interagency CBD efforts to ensure a coordinated and unified DoD strategy, project portfolio, and position on important interagency efforts. The CBDP maintains two major interagency forums for the development of technology the Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) with Department of Health and Human Services (HHS) and the Technical Coordination Working Group (TCWG) with the Department of Homeland Security (DHS) and Environmental Protection Agency (EPA).

The CBDP also supports the USD policy by participates heavily in Policy Coordination Committee meetings chaired by the National Security Council on chemical and biological defense issues.

The Office of the Assistant Secretary of Defense for Nuclear, Chemical, and Biological Defense Programs is the office of primary responsibility for DoD Instructions (DoDIs) 5210.88, Security Standards for Safeguarding Biological Select Agents and Toxins (BSAT), and 5210.65, Security Standards for Safeguarding Chemical Agent. The BSAT instruction applies to five DoD laboratories registered by the Centers for Disease Control and Prevention (CDC) to use and maintain BSAT. The chemical instruction applies to nine DoD laboratories (government and contract) that use and maintain chemical agent required to be tracked by the Chemical Weapons Convention (CWC) and two chemical weapons destruction facilities at Pueblo, CO and Blue Grass, KY. CWC allows the United States to operate one Single Small Scale Facility at Aberdeen Proving Ground to produce chemical agent for protective purposes within the United States. The CWC also allows the United States to operate a second protective purposes facility at Fort Leonard Wood, MO, to provide agent specifically to that site for defensive training purposes.

The Secretary of the Army delegated the DoD EA responsibility for the DoD BSAT program to The Surgeon General of the Army, and established a BSAT Biorisk Program Office (BBPO) to provide oversight of the program.

At the request of Congress, the Secretary of Defense designated the DASD(CBD) responsible for managing the infrastructure for the CBDP in order to minimize duplication of effort both within DoD and other agencies of the federal government. As the infrastructure manager DASD(CBD) leads efforts to support infrastructure management and coordination across the CBDP Enterprise on relevant issues and matters.

2015 Annual Report to Congress